Skip to main content
. 2022 Nov 7;13:1047231. doi: 10.3389/fgene.2022.1047231

FIGURE 9.

FIGURE 9

Drug sensitivity analysis. The IC50 of Axitinib, Erlotinib, Doxorubicin, Bortezomib, Gefitinib, Gemcitabine, Paclitaxel, Tipifarnib, Vinblastine, Vinblastine, Cisplatin and Methotrexate was analyzed in high-risk and low-risk groups (A–L).